Rapid infusion of ofatumumab appears safe and reduces infusion related reactions in patients with relapsed/refractory Chronic Lymphocytic Leukemia

Anti-CD20 monoclonal antibodies, such as ofatumumab and rituximab, have been demonstrated to be effective in B-cell Lymphoma and CLL. However, the recommended administration of ofatumumab for CLL requires lengthy infusion times and side effects are common during and after infusion. On 7th July 2017, in The Oncologist, William Donnellan, MD, from the Sarah Cannon Research […]

Read More

Congress must fix 340B to save it from hospital greed.

The 340B program was intended to help uninsured, poor, or vulnerable patients access needed medical care. Unfortunately, it has instead become a profit-generator for hospitals abusing the program to make huge profits! 340B is literally costing us billions of dollars in unnecessary spending by shifting cancer care into the much more expensive hospital setting. Congress […]

Read More

Medical Assistant Hiring Event

Tennessee Oncology is seeking Medical Assistants for our clinics throughout the Middle Tennessee area. Our openings are in the Clarksville, Dickson, Franklin, Nashville, Hermitage,  Lebanon, Springfield, Murfreesboro, and Tullahoma areas. We will be conducting interviews on Wednesday, August 2nd at our Midtown Medical Plaza location in Nashville. Interviews will be conducted from 9:00 am-12:00 pm and […]

Read More

Tennessee Oncology Group Finds Growth Bonanza in Clinical Trials

Andrew Smith | June 09, 2017 Tennessee Oncology was a relatively small practice until 1992, which is when F. Anthony Greco, MD, left Vanderbilt University Medical Center to become its fourth partner. Greco came with the then-radical idea that he could perform more trial work at a private practice than he could at a larger […]

Read More